TET1 (30) is a tumor-suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway, and TBX3 (31) acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. Here, TBX3 is linked to colonic neoplasm.